CCM
PTLA

Chicago Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Chicago Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-176,000
Closed -$3.17M – 20
2020
Q2 		$3.17M Buy
+176,000
New +$2.45M 8.04% 5

Chicago Capital Management's PTLA Position: Q3 2020 in Review

Chicago Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 176,000 shares — an estimated $3.17M sold.

Chicago Capital Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $3.17M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Chicago Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Chicago Capital Management sold 176,000 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.17M.
  • Chicago Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Chicago Capital Management's Portola Pharmaceuticals, Inc. position peaked at $3.17M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Chicago Capital Management's 13F filing for Q3 2020, filed 6 Nov 2020.